Although the temporary discontinuation of renin–angiotensin system (RAS) inhibitors before contrast exposure is a common clinical practice, meta-analytic evidence indicates that such withdrawal does not consistently reduce the risk of contrast-associated acute kidney injury (CA-AKI). Here, REN is linked to acute kidney injury.